Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Research Article

The Value of Computed Tomography in Recurrent Laryngeal Cancer Following Organ Preservation Therapy

Author(s): Snir Dekalo, Hagit Shoffel-Havakuk*, Aviram Mizrachi, Yehudit Lukman, Thomas Shpitzer, Yaniv Hamzany and Gideon Bachar

Volume 20, 2024

Published on: 19 October, 2023

Article ID: e15734056240028 Pages: 7

DOI: 10.2174/0115734056240028231016074150

Price: $65

Abstract

Aim: This study aims to assess the accuracy of computed tomography (CT) in detecting recurrent laryngeal tumors after failed chemoradiation therapy (CRT).

Background: Local recurrence of laryngeal tumors following CRT has been reported in approximately 25%, yet it is often difficult to detect.

Methods: Ten patients with laryngeal cancer who failed CRT and subsequently underwent salvage total laryngectomy were included. The laryngeal subsites involved in the tumor were identified based on postoperative pathology. The corresponding preoperative CT scans were selected for review by seven experts (head-and-neck surgeons or radiologists) who scored the extent of tumor spread on each scan on a 5-point scale, from no tumor detected to clearly visible tumor.

Results: The rates of high tumor detectability (scores 4-5) varied according to laryngeal subsite, from 75% in the glottic region, to 45% in the subglottic region, and to 19% in the supraglottic region (P=0.01). The detectability rates were higher on scans performed 2 years or more after CRT.

Conclusion: The CT evaluation of laryngeal cancer after CRT has limited value, particularly in the epiglottis and subglottis.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy